喉鳞状细胞癌组织中血管生成拟态与临床病理学特征关系的研究

冯彦, 王斌全, 梁钢, 等. 喉鳞状细胞癌组织中血管生成拟态与临床病理学特征关系的研究[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(23): 2071-2075. doi: 10.13201/j.issn.1001-1781.2015.23.015
引用本文: 冯彦, 王斌全, 梁钢, 等. 喉鳞状细胞癌组织中血管生成拟态与临床病理学特征关系的研究[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(23): 2071-2075. doi: 10.13201/j.issn.1001-1781.2015.23.015
FENG Yan, WANG Binquan, LIANG Gang, et al. Relationship between vasculogenic mimicry and clinic pathological features in laryngeal carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(23): 2071-2075. doi: 10.13201/j.issn.1001-1781.2015.23.015
Citation: FENG Yan, WANG Binquan, LIANG Gang, et al. Relationship between vasculogenic mimicry and clinic pathological features in laryngeal carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(23): 2071-2075. doi: 10.13201/j.issn.1001-1781.2015.23.015

喉鳞状细胞癌组织中血管生成拟态与临床病理学特征关系的研究

  • 基金项目:

    2014年山西省基础研究计划(青年科技研究基金)(No:2014021037-2)

    2013年度山西医科大学第一医院青年基金项目(No:YQ1310)

    2012年度山西医科大学青年基金(No:Q02201222)

详细信息
    通讯作者: 王斌全,E-mail:wbq_xy@sxent.org
  • 中图分类号: R739.65

Relationship between vasculogenic mimicry and clinic pathological features in laryngeal carcinoma

More Information
  • 目的: 探讨喉鳞状细胞癌(LSCC)组织中内皮依赖性血管和血管生成拟态(VM)的存在及其与临床病理学特征之间的关系。方法: 采用组织芯片技术,进行苏木精-伊红染色、CD34免疫组织化学染色以及CD34/过碘酸雪夫双重染色技术检测138例喉癌组织中内皮依赖性血管和VM的表达。分析喉癌组织中内皮依赖性血管、VM与临床病理学特征之间的关系。结果: LSCC中存在VM的比例为26.23%(32/122),肿瘤微血管密度(MVD)平均值为12.61个/高倍视野。不同年龄、性别、临床分型、临床分期、病理分级、T分期及N分期,VM的阳性表达以及肿瘤MVD的表达差异均无统计学意义(P>0.05),但 ≥ 60岁年龄组VM和MVD均略高于<60岁组,低分化组VM和MVD略高于高分化+中分化组,N1~3组VM和MVD高于N0组。喉癌组织中VM的表达与MVD存在正相关关系(r=0.1927,P<0.05)。表明年龄越大、组织分化越差、分期越高,组织中VM及内皮依赖性血管的表达呈现升高的趋势。结论: VM是喉癌中存在的一种血液供应模式,VM的存在可能与喉癌的复发和转移有关。
  • 加载中
  • [1]

    SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012,62:10-29.

    [2]

    SHIRAKAWA K, KOBAYASHI H, HEIKE Y, et al. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft[J].Cancer Res,2002,62:560-566.

    [3]

    SHARMA N, SEFTOR R E, SEFTOR E A, et al. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations:role in vasculogenic mimicry[J]. Prostate, 2002,50:189-201.

    [4]

    GUZMAN G, COTLER S J, LIN A Y, et al. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma[J]. Arch Pathol Lab Med, 2007,131:1776-1781.

    [5]

    YUE W Y, CHEN Z P. Does vasculogenic mimicry exist in astrocytoma[J]. J Histochem Cytochem, 2005, 53:997-1002.

    [6]

    WANG W, LIN P, HAN C, et al. Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma[J]. J Exp Clin Cancer Res, 2010,29:60-60.

    [7]

    FOLKMAN J. Can mosaic tumor vessels facilitate molecular diagnosis of cancer[J]?Proc Natl Acad Sci U S A, 2001, 98:398-400.

    [8]

    KAKU T, KAMURA T, KINUKAWA N, et al. Angiogenesis in endometrial carcinoma[J]. Cancer, 1997,80:741-747.

    [9]

    DALAL S, BERRY A M, CULLINANE C J, et al. Vascular endothelial growth factor:a therapeutic target for tumors of the Ewing's sarcoma family[J]. Clin Cancer Res, 2005,11:2364-2378.

    [10]

    MANIOTIS A J, FOLBERG R, HESS A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J]. Am J Pathol,1999,155:739-752.

    [11]

    CANOGLU A, GOGUS C, BEDUK Y, et al. Mi crovessel density as a prognostic marker in bladder carcinoma:correlation with tumor grade stage and prognosis[J]. Int Urol Nephrol, 2004,36:401-405.

    [12]

    TSUT SUI S, KUME M, ERA S. Prognostic value of microvessel density in invasive ductal carcinoma of the breast[J]. Breast Cancer, 2003,10:312-319.

    [13]

    WEIDNER N, SEMPLE J P, WELCH W R, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J]. N Engl J Med,1991,324:1-8.

  • 加载中
计量
  • 文章访问数:  76
  • PDF下载数:  31
  • 施引文献:  0
出版历程
收稿日期:  2015-09-24

目录